SlideShare una empresa de Scribd logo
1 de 18
Cushing
Syndrome
Cushing syndrome defination-
Clinical features/abnormalities due to hypercortisolism (excessive production of glucocorticoid or cortisol)
from any cause .
Cushing disease-
Pituitary dependent excessive ACTH secretion by pituitary corticotropin tumors.
Etiopathogenesis
Causes:
1.Exogenous:
● Administration of corticosteroids(Iatrogenic).
2. Endogenous:
a. ACTH dependent(80%):
● Primary hypersecretion of ACTH by pituitary diseases(Cushing disease)-
ACTH secreting pituitary adenome or hyperplasia
● Secretion of ACTH by non pituitary neoplasms- small cell carcinoma lung,
bronchial carcinoid.
a. ACTH independent (20%)
● Primary adrenocortical neoplasms- adrenal adenoma and adrenal cortical
carcinoma
● Primary cortical hyperplasia
ACTH secreting pituitary adenoma
● Male:female = 1:4
● Age- young adults
● Causes:
1. ACTH producing pituitary microadenoma- most common cause
2. ACTH secreting macroadenoma
3. Corticotroph cell hyperplasia without discrete adenoma
● Elevated ACTH -> nodular cortical hyperplasia -> hypercortisolism.
Secretion of ACTH by non pituitary tumors
● Males > females
● Age: 40 - 60
● Causes:
1. Small cell carcinoma of lung - most common cause
2. Carcinoids
3. Medullary carcinoma of thyroid
4. PanNETs
5. Neuroendocrine neoplasm - ectopic CRH -> ACTH secretion ->
hypercortisolism
ACTH independent Cushing syndrome
● Increased cortiol serum levels - and low ACTH levels
● Causes- primary adrenal neoplasms
● Adrenocortical carcinoma- activating mutation of CTNNB1( beta catenin)
Inactivating mutation of TP53, MEN1, PRKAR1A
● Bilateral marcronodular adrenal hyperplasia- ARMC5 (tumor suppressor)
Clinical features of cushing syndrome
Lab diagnosis
 Urine and blood tests. These tests measure hormone levels and show if the
body is making too much cortisol. For the urine test, you may be asked to
collect your urine over a 24-hour period. Cortisol, ACTH and other hormones
are be measured in urine and blood samples.
 Saliva test. Cortisol levels typically rise and fall during the day. In people
without Cushing syndrome, cortisol drops in the evening. By looking at
cortisol levels from a small sample of saliva collected at night, the health
care team can see if cortisol levels are too high.
 Imaging tests. CT or MRI scans can take pictures of the pituitary and adrenal
glands to see if anything shows up, such as tumors.
 Inferior petrosal sinus sampling. This test can help decide if Cushing
syndrome is caused by an ACTH-producing pituitary adenoma, or ACTH-
producing tumor in another organ. For the test, blood samples are taken
from the veins that drain the pituitary gland, called the inferior petrosal
sinuses.
CUSHING SYNDROME
MORPHOLOGY
The main lesions of Cushing syndrome are found in the pituitary and
adrenal glands.The pituitary shows changes regardless of the cause.The
most common alteration, resulting from high levels of endogenous or
exogenous glucocorticoids, is termed Crooke hyaline change. In this
condition, the normal granular, basophilic cytoplasm of the ACTH-
producing cells in the anterior pituitary becomes homogeneous and
paler.This alteration is the result of
The accumulation of intermediate keratin filaments in the cytoplasm, a finding that is
also seen in “Crooke cell” corticotroph adenoma (discussed earlier).
Depending on the cause of the hypercortisolism, the adrenals show one of the
following abnormalities: (1) cortical atrophy, (2) diffuse hyperplasia, (3) macronodular
or micronodular hyperplasia, and (4) an adenoma or carcinoma. In patients in whom
the syndrome results from exogenous glucocorticoids, suppression of endogenous
ACTH results in bilateral cortical atrophy, due to a lack of stimulation of the zonae
fasciculata and reticularis by ACTH. The zona glomerulosa is of normal thickness in
such cases, because this portion of the cortex functions independently of ACTH. In
contrast, in cases of endogenous hypercortisolism, the adrenals either are
hyperplastic or contain a cortical neoplasm.
Diffuse hyperplasia is found in individuals with ACTH-dependent Cushing syndrome
(Fig. 24.42). Both glands are enlarged, either subtly or markedly, weighing up to 30
g. The adrenal cortex is diffusely thickened and variably nodular, although the latter
is not as pronounced as seen in cases of ACTH-independent nodular hyperplasia.
Microscopically, the hyperplastic cortex demonstrates an expanded “lipid-poor”
zona reticularis, comprising compact, eosinophilic cells, surrounded by an outer
zone of vacuolated “lipid-rich” cells, resembling those seen in the zona fasciculata.
Any nodules present are usually composed of vacuolated “lipid-rich” cells, which
account for the yellow color of diffusely hyperplastic glands. In contrast, in
macronodular hyperplasia the adrenals are almost entirely replaced by prominent
nodules of varying sizes (10 to 30 mm), which contain an admixture of lipid-poor
and lipid-rich cells. Unlike diffuse hyperplasia, the areas between the macroscopic
nodules also demonstrate evidence of microscopic
nodularity. Micronodular hyperplasia is composed of 1- to 3-mm (typically <10
mm) darkly pigmented (brown to black) micronodules with atrophic intervening
areas (Fig. 24.43). The pigment is believed to be lipofuscin, a wear-and-tear
pigment (Chapter 2).
Primary adrenocortical neoplasms causing Cushing syndrome may be malignant
or benign. Functional adenomas or carcinomas are not morphologically distinct
from nonfunctioning adrenal neoplasms (described later). Both the benign and
malignant lesions are more common in women in their 30s to 50s. Adre-
nocortical adenomas are yellow tumors surrounded by thin or well-developed
capsules, and most weigh less than 30 g. Microscopi- cally, they are composed
of cells that are similar to those encountered in the normal zona fasciculata. The
carcinomas associated with Cushing syndrome, by contrast, tend to be larger
than the adenomas.These tumors (detailed later) are unencap- sulated masses
frequently exceeding 200 to 300 g in weight that have all of the anaplastic
characteristics of cancer.With functioning tumors, both benign and malignant,
the adjacent adrenal cortex and that of the contralateral adrenal gland are
atrophic, as a result of suppression of endogenous ACTH by high cortisol levels.
Complications :
 Muscle weakness : hypercortisolism causes selective atrophy of fast twitch
type 2 Myofibers with resultant decreased muscle mass and proximal limb
weakness.
 Secondary diabetes : glucocorticoids induce gluconeogenesis and inhibit the
uptake of glucose by cells , resulting in secondary diabetes .
 Cutaneous haemorrhages ( striae) : the skin become thin and fragile and is
easily bruised. Leading to cutaneous haemorrhages , particularly in
abdominal area.
 Osteoporosis: cortisol increses resumption of bone and consequent
osteoporosis.
 Increase risk for a variety of infections glucocorticoids suppress the immune
response. Patients are at increasd history risk for a variety of infections .
THANK
YOU

Más contenido relacionado

Similar a Cushing's Syndrome and aboout it(1).pptx

Approach to cushing syndrome dr vidyakar
Approach to cushing syndrome dr vidyakarApproach to cushing syndrome dr vidyakar
Approach to cushing syndrome dr vidyakar
Sachin Verma
 
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdfadrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
mekuriatadesse
 

Similar a Cushing's Syndrome and aboout it(1).pptx (20)

Adrenal tumors
Adrenal tumorsAdrenal tumors
Adrenal tumors
 
Medicine 5th year, 2 lectures/adrenal gland (Dr. Taha Mahwy)
Medicine 5th year, 2 lectures/adrenal gland (Dr. Taha Mahwy)Medicine 5th year, 2 lectures/adrenal gland (Dr. Taha Mahwy)
Medicine 5th year, 2 lectures/adrenal gland (Dr. Taha Mahwy)
 
2_2019_05_04!10_09_05_AMtyvvgģgggggggggg
2_2019_05_04!10_09_05_AMtyvvgģgggggggggg2_2019_05_04!10_09_05_AMtyvvgģgggggggggg
2_2019_05_04!10_09_05_AMtyvvgģgggggggggg
 
cushing syndrome-1.pdf
cushing syndrome-1.pdfcushing syndrome-1.pdf
cushing syndrome-1.pdf
 
Cushing syndrome
Cushing syndromeCushing syndrome
Cushing syndrome
 
Cushing syndrome
Cushing syndromeCushing syndrome
Cushing syndrome
 
Cushing syndrome.pptx
Cushing syndrome.pptxCushing syndrome.pptx
Cushing syndrome.pptx
 
Cushing Syndrome
Cushing SyndromeCushing Syndrome
Cushing Syndrome
 
Lecture 5 ( Hyperadrenalism pathology).pdf
Lecture 5 ( Hyperadrenalism   pathology).pdfLecture 5 ( Hyperadrenalism   pathology).pdf
Lecture 5 ( Hyperadrenalism pathology).pdf
 
Cushingsyndromeandaddisondisease 130618105538-phpapp01
Cushingsyndromeandaddisondisease 130618105538-phpapp01Cushingsyndromeandaddisondisease 130618105538-phpapp01
Cushingsyndromeandaddisondisease 130618105538-phpapp01
 
3. Cushing's_syndrome.pptx
3. Cushing's_syndrome.pptx3. Cushing's_syndrome.pptx
3. Cushing's_syndrome.pptx
 
Adrenal gland disorders
Adrenal gland disordersAdrenal gland disorders
Adrenal gland disorders
 
Lecture 8. adrenal cortex diseases
Lecture 8. adrenal cortex diseasesLecture 8. adrenal cortex diseases
Lecture 8. adrenal cortex diseases
 
cushings.pptx
cushings.pptxcushings.pptx
cushings.pptx
 
Cushing syndrome and addison disease
Cushing syndrome and addison diseaseCushing syndrome and addison disease
Cushing syndrome and addison disease
 
Adrenal Gland.pptx
Adrenal Gland.pptxAdrenal Gland.pptx
Adrenal Gland.pptx
 
Diseases of adrenal cortex and medulla
Diseases of adrenal cortex and medullaDiseases of adrenal cortex and medulla
Diseases of adrenal cortex and medulla
 
Cushing's Syndrome by Dr. Aryan
Cushing's Syndrome by Dr. AryanCushing's Syndrome by Dr. Aryan
Cushing's Syndrome by Dr. Aryan
 
Approach to cushing syndrome dr vidyakar
Approach to cushing syndrome dr vidyakarApproach to cushing syndrome dr vidyakar
Approach to cushing syndrome dr vidyakar
 
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdfadrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
 

Último

Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 

Último (20)

Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdf
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 

Cushing's Syndrome and aboout it(1).pptx

  • 2. Cushing syndrome defination- Clinical features/abnormalities due to hypercortisolism (excessive production of glucocorticoid or cortisol) from any cause . Cushing disease- Pituitary dependent excessive ACTH secretion by pituitary corticotropin tumors.
  • 3. Etiopathogenesis Causes: 1.Exogenous: ● Administration of corticosteroids(Iatrogenic). 2. Endogenous: a. ACTH dependent(80%): ● Primary hypersecretion of ACTH by pituitary diseases(Cushing disease)- ACTH secreting pituitary adenome or hyperplasia ● Secretion of ACTH by non pituitary neoplasms- small cell carcinoma lung, bronchial carcinoid. a. ACTH independent (20%) ● Primary adrenocortical neoplasms- adrenal adenoma and adrenal cortical carcinoma ● Primary cortical hyperplasia
  • 4. ACTH secreting pituitary adenoma ● Male:female = 1:4 ● Age- young adults ● Causes: 1. ACTH producing pituitary microadenoma- most common cause 2. ACTH secreting macroadenoma 3. Corticotroph cell hyperplasia without discrete adenoma ● Elevated ACTH -> nodular cortical hyperplasia -> hypercortisolism.
  • 5. Secretion of ACTH by non pituitary tumors ● Males > females ● Age: 40 - 60 ● Causes: 1. Small cell carcinoma of lung - most common cause 2. Carcinoids 3. Medullary carcinoma of thyroid 4. PanNETs 5. Neuroendocrine neoplasm - ectopic CRH -> ACTH secretion -> hypercortisolism
  • 6. ACTH independent Cushing syndrome ● Increased cortiol serum levels - and low ACTH levels ● Causes- primary adrenal neoplasms ● Adrenocortical carcinoma- activating mutation of CTNNB1( beta catenin) Inactivating mutation of TP53, MEN1, PRKAR1A ● Bilateral marcronodular adrenal hyperplasia- ARMC5 (tumor suppressor)
  • 7. Clinical features of cushing syndrome
  • 8.
  • 9.
  • 10. Lab diagnosis  Urine and blood tests. These tests measure hormone levels and show if the body is making too much cortisol. For the urine test, you may be asked to collect your urine over a 24-hour period. Cortisol, ACTH and other hormones are be measured in urine and blood samples.  Saliva test. Cortisol levels typically rise and fall during the day. In people without Cushing syndrome, cortisol drops in the evening. By looking at cortisol levels from a small sample of saliva collected at night, the health care team can see if cortisol levels are too high.  Imaging tests. CT or MRI scans can take pictures of the pituitary and adrenal glands to see if anything shows up, such as tumors.  Inferior petrosal sinus sampling. This test can help decide if Cushing syndrome is caused by an ACTH-producing pituitary adenoma, or ACTH- producing tumor in another organ. For the test, blood samples are taken from the veins that drain the pituitary gland, called the inferior petrosal sinuses.
  • 11. CUSHING SYNDROME MORPHOLOGY The main lesions of Cushing syndrome are found in the pituitary and adrenal glands.The pituitary shows changes regardless of the cause.The most common alteration, resulting from high levels of endogenous or exogenous glucocorticoids, is termed Crooke hyaline change. In this condition, the normal granular, basophilic cytoplasm of the ACTH- producing cells in the anterior pituitary becomes homogeneous and paler.This alteration is the result of
  • 12.
  • 13. The accumulation of intermediate keratin filaments in the cytoplasm, a finding that is also seen in “Crooke cell” corticotroph adenoma (discussed earlier). Depending on the cause of the hypercortisolism, the adrenals show one of the following abnormalities: (1) cortical atrophy, (2) diffuse hyperplasia, (3) macronodular or micronodular hyperplasia, and (4) an adenoma or carcinoma. In patients in whom the syndrome results from exogenous glucocorticoids, suppression of endogenous ACTH results in bilateral cortical atrophy, due to a lack of stimulation of the zonae fasciculata and reticularis by ACTH. The zona glomerulosa is of normal thickness in such cases, because this portion of the cortex functions independently of ACTH. In contrast, in cases of endogenous hypercortisolism, the adrenals either are hyperplastic or contain a cortical neoplasm.
  • 14. Diffuse hyperplasia is found in individuals with ACTH-dependent Cushing syndrome (Fig. 24.42). Both glands are enlarged, either subtly or markedly, weighing up to 30 g. The adrenal cortex is diffusely thickened and variably nodular, although the latter is not as pronounced as seen in cases of ACTH-independent nodular hyperplasia. Microscopically, the hyperplastic cortex demonstrates an expanded “lipid-poor” zona reticularis, comprising compact, eosinophilic cells, surrounded by an outer zone of vacuolated “lipid-rich” cells, resembling those seen in the zona fasciculata. Any nodules present are usually composed of vacuolated “lipid-rich” cells, which account for the yellow color of diffusely hyperplastic glands. In contrast, in macronodular hyperplasia the adrenals are almost entirely replaced by prominent nodules of varying sizes (10 to 30 mm), which contain an admixture of lipid-poor and lipid-rich cells. Unlike diffuse hyperplasia, the areas between the macroscopic nodules also demonstrate evidence of microscopic
  • 15.
  • 16. nodularity. Micronodular hyperplasia is composed of 1- to 3-mm (typically <10 mm) darkly pigmented (brown to black) micronodules with atrophic intervening areas (Fig. 24.43). The pigment is believed to be lipofuscin, a wear-and-tear pigment (Chapter 2). Primary adrenocortical neoplasms causing Cushing syndrome may be malignant or benign. Functional adenomas or carcinomas are not morphologically distinct from nonfunctioning adrenal neoplasms (described later). Both the benign and malignant lesions are more common in women in their 30s to 50s. Adre- nocortical adenomas are yellow tumors surrounded by thin or well-developed capsules, and most weigh less than 30 g. Microscopi- cally, they are composed of cells that are similar to those encountered in the normal zona fasciculata. The carcinomas associated with Cushing syndrome, by contrast, tend to be larger than the adenomas.These tumors (detailed later) are unencap- sulated masses frequently exceeding 200 to 300 g in weight that have all of the anaplastic characteristics of cancer.With functioning tumors, both benign and malignant, the adjacent adrenal cortex and that of the contralateral adrenal gland are atrophic, as a result of suppression of endogenous ACTH by high cortisol levels.
  • 17. Complications :  Muscle weakness : hypercortisolism causes selective atrophy of fast twitch type 2 Myofibers with resultant decreased muscle mass and proximal limb weakness.  Secondary diabetes : glucocorticoids induce gluconeogenesis and inhibit the uptake of glucose by cells , resulting in secondary diabetes .  Cutaneous haemorrhages ( striae) : the skin become thin and fragile and is easily bruised. Leading to cutaneous haemorrhages , particularly in abdominal area.  Osteoporosis: cortisol increses resumption of bone and consequent osteoporosis.  Increase risk for a variety of infections glucocorticoids suppress the immune response. Patients are at increasd history risk for a variety of infections .